Assembly Biosciences, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2016 | — | $79.9M | $28.6M |
| FY2017 | — | $113.1M | $82.0M |
| FY2018 | — | $210.7M | $41.5M |
| FY2019 | — | $273.2M | $46.7M |
| FY2020 | — | $240.6M | $59.4M |
| FY2021 | — | $168.9M | $45.6M |
| FY2022 | — | $82.7M | $52.4M |
| FY2023 | — | $41.1M | $19.8M |
| FY2024 | — | $33.4M | $38.3M |
| FY2025 | — | $206.8M | $58.5M |